1. Home
  2. KBR vs RGEN Comparison

KBR vs RGEN Comparison

Compare KBR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KBR Inc.

KBR

KBR Inc.

HOLD

Current Price

$40.23

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.88

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBR
RGEN
Founded
1901
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
8.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
KBR
RGEN
Price
$40.23
$164.88
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$55.00
$174.90
AVG Volume (30 Days)
1.5M
630.5K
Earning Date
10-30-2025
10-28-2025
Dividend Yield
1.64%
N/A
EPS Growth
21.27
N/A
EPS
2.89
0.03
Revenue
$8,041,000,000.00
$707,890,000.00
Revenue This Year
$2.43
$17.84
Revenue Next Year
$4.38
$12.44
P/E Ratio
$12.67
$5,365.43
Revenue Growth
9.67
11.74
52 Week Low
$39.52
$102.97
52 Week High
$60.98
$182.52

Technical Indicators

Market Signals
Indicator
KBR
RGEN
Relative Strength Index (RSI) 35.82 56.56
Support Level $39.52 $156.01
Resistance Level $43.55 $167.74
Average True Range (ATR) 1.00 4.38
MACD -0.36 -0.10
Stochastic Oscillator 14.20 75.62

Price Performance

Historical Comparison
KBR
RGEN

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: